Evento
Effect of hexachlorobenzene (hcb) and protein x of the hepatitis b virus (hbv) on liver cell growth dysregulation
Coli, Lucía; Mathel, Verónica; Ridruejo, Ezequiel; Gentile, Emiliano; Kurtz, Melisa Lidia Amelia
; Miret, Noelia; Oubiña, Jose Raul
; Alvarez, Laura
Colaboradores:
Curino, Alejandro Carlos
; Maccioni, Mariana
; Schaiquevich, Paula Susana
; Duran, Hebe Alicia
Tipo del evento:
Reunión
Nombre del evento:
LXVI Reunión Anual de La Sociedad Argentina de Investigación Clínica; LXIX Reunión Anual de La Sociedad Argentina de Inmunología; LIII Reunión Anual de La Asociación Argentina de Farmacología Experimental y XI Reunión Anual de La Asociación Argentina De Nanomedicinas
Fecha del evento:
17/11/2021
Institución Organizadora:
Sociedad Argentina de Investigación Clínica;
Sociedad Argentina de Inmunología;
Asociación Argentina de Farmacología Experimental;
Asociación Argentina de Nanomedicinas;
Título de la revista:
Medicina
Editorial:
Fundación Revista Medicina
ISSN:
1669-9106
e-ISSN:
0025-7680
Idioma:
Inglés
Clasificación temática:
Resumen
Chronic hepatitis B and exposure to persistent organic pollutants (POPs) can lead to cellular hepatocarcinoma (HCC), the most common liver tumor. HBV DNA encodes transactivator X (HBx). HCB is a COP promoter of hepatic preneoplastic foci. We have shown that HCB deregulates cell growth in rat liver and HepG2 cells, involving TGF-β1, a reversed effect with an Rβ1 inhibitor. Objectives: To analyze in vitro 2 models of HCC generation -associated to HCB or to the expression of HBx- and in vivo the hepatic and angiogenic promoter HCB effect in Balb/c nude mice inoculated with HepG2. M&M: the HCB effect on PCNA (Western blot)/TGF-β1 (RT-PCR) was studied in vitro in: 1.1) Huh-7: HCB at various doses (0.005, 0.05, 0.5 and 5 µM ) and times (15, 30, 60, 90 and 120 min); 1.2) Huh-7 transiently transfected with HBx; 2) HepG2.2.15 (with stable expression of HBV) and 3) EA-hy926 (endothelial). In 1.2, 2 and 3 5 µM HCB, 24h was used. Mice: HCB i.p. (0.3 and 3 mg/ kg), and were inoculated with HepG2. Were evaluated: a) PCNA, b) TGF-β1, c) No . of tumor areas, d) histology (H&E) and e) No . of vessels/mm2 . Results: In Huh-7, TGF-β1 increased (20%, p <0.05; 69% and 78%, p <0.01, with 0.05, 0.5 and 5 µM HCB, respectively) and PCNA (45% and 60%, p <0.01, with 0.5 and 5 µM HCB, respectively). In Huh-7 / HBx, PCNA and TGF-β1 increased 66% and 71% (p <0.01). In Huh-7 / HBx and 5 µM HCB, PCNA increased 120% (p <0.001). In HepG2.2.15 PCNA was overexpressed 76% (p <0.001). In EA-hy926, PCNA (29%, p <0.05) and TGF-β1 (43%, p <0.01) increased. In mice, PCNA (39%; p <0.01), TGF-β1 (48%; p <0.01), preneoplastic areas (320%; p <0.001) and vascularization (35%; p <0.01). Conclusions: HCB promotes preneoplastic cell proliferation and angiogenesis in nude mice inoculated with HepG2, while HCB and HBx induce in vitro cell proliferation associated with the increase of TGF-β1 in the examined lines, a proliferative effect increased to that promoted by the HCB being able to participate in the induction of HCC.
Palabras clave:
HEXACHLOROBENZENE
,
LIVER
,
TOXICITY
,
HEPATITIS b
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos(OCA PQUE. CENTENARIO)
Eventos de OFICINA DE COORDINACION ADMINISTRATIVA PQUE. CENTENARIO
Eventos de OFICINA DE COORDINACION ADMINISTRATIVA PQUE. CENTENARIO
Citación
Effect of hexachlorobenzene (hcb) and protein x of the hepatitis b virus (hbv) on liver cell growth dysregulation; LXVI Reunión Anual de La Sociedad Argentina de Investigación Clínica; LXIX Reunión Anual de La Sociedad Argentina de Inmunología; LIII Reunión Anual de La Asociación Argentina de Farmacología Experimental y XI Reunión Anual de La Asociación Argentina De Nanomedicinas; Buenos Aires; Argentina; 2021; 243-243
Compartir